China Meheco Group: The subsidiary Tianfang Pharmaceutical's Generic Consistency Evaluation of Rosuvastatin Calcium Tablets has been approved.

Breakings ·  Jun 11 17:50
China Meheco Group announced that its subsidiary, Tianfang Pharmaceutical, has received the approval from the National Medical Products Administration to issue the Approval Notice for Supplementary Application of Betahistine Hydrochloride Tablets. The product passed the consistency evaluation of generic drugs in terms of quality and efficacy. Betahistine hydrochloride tablets are mainly used to treat symptoms related to Meniere's disease, and the original drug was produced by Serc.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment